Continuing innovations in cancer diagnostics Insight Genetics, Nashville, Tenn, has just inked an agreement with QIAGEN, Hilden, Germany, with US headquarters in Germantown, Md, whereby the companies will develop a cancer diagnostic test relat
Read MoreThe report in The Lancet describes the development of the assay based on specimens from 361 patients who underwent surgery at the University of California, San Francisco.
Read More
Lale White, executive chairman and CEO, XIFIN Economic pressures, legislative mandates, and technological advancements are driving significant changes in the diagnostic services segment, while reimbursement for lab testing and diagnost
Read More
Changing the role of informatics in personalized medicine
Read MoreA mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer’s development but in its continued growth.
Read More